Monday, August 21, 2017

 ipadcvilleaug17   Click here 
   for the latest
   digital edition
   of OurHealth
   magazine!

Featured Stories

UVA, Bon Secours to Collaborate on Liver Transplant Care

University of Virginia Health System (UVA) and the Bon Secours Liver Institute of Virginia will collaboratively care for patients at Bon Secours’ facilities in Richmond and Newport News that may need liver transplants at UVA. The Bon Secours facilities include St. Mary’s Hospital in Richmond and Mary Immaculate Hospital in Newport News.

Under the affiliation agreement, care teams from Bon Secours and UVA will co-manage patients at the Bon Secours Liver Institute of Virginia with liver disease – including those with advanced cirrhosis and liver cancer – who will be evaluated for a liver transplant.

“Our goal is to provide patients in the Richmond and Hampton Roads area who have liver disease with convenient, expert care while limiting their travel time,” said Thomas Auer, MD, MHA, chief executive officer of Bon Secours Virginia Medical Group.

“Through this affiliation, we seek to bring UVA’s expertise to more convenient locations and closer to home for patients throughout the Commonwealth,” said Pamela M. Sutton-Wallace, chief executive officer of UVA Medical Center.

Patients who may be candidates for a liver transplant will receive a preliminary evaluation at a Bon Secours Liver Institute of Virginia location, followed by a formal transplant evaluation at the UVA Transplant Center. Patients determined to be candidates for a transplant will receive ongoing disease management and care from teams at the Bon Secours Liver Institute of Virginia, returning to UVA periodically throughout their time on the United Network for Organ Sharing (UNOS) waitlist.

“During this pre-transplant period, patients can largely remain in their home community and receive coordinated, well-managed care from Bon Secours and UVA to prepare them for a transplant,” said Mitchell Shiffman, MD, medical director of Bon Secours Liver Institute.

Following transplant surgeries at the UVA Transplant Center, patients alternate follow-up visits between UVA and Bon Secours, with care coordinated between the two institutions. Depending on the progress of the patient’s recovery, these visits may be formally transferred to Bon Secours within a short timeframe following transplant. UVA clinicians remain engaged with the patient’s care and are available as needed.

“Following the transplant, we will work closely with our colleagues at Bon Secours to monitor and assist patients as they recover and get back to their regular routines,” said Daniel Maluf, MD, director of living donor transplantation at UVA.

“We believe this collaboration will enable patients to receive high-quality care in a more streamlined way,” said Shawn Pelletier, MD, director of liver transplantation at UVA.

####

UVA Health System is an academic health system that includes a 612-bed hospital, the UVA School of Medicine, a level I trauma center, nationally recognized cancer and heart centers and primary and specialty clinics throughout Central Virginia. UVA is recognized for excellence by U.S. News & World Report, Best Doctors in Americaand America's Top Doctors.

Related items

  • UVA, Inova Award Research Seed Funding Grants to Joint Research Teams

    The Inova Health System (Inova) and the University of Virginia (UVA) announced today that they have awarded $450,000 to nine UVA-Inova joint research teams for projects focused on how to better predict, prevent and treat disease. In the fall of 2016, Inova and UVA announced a comprehensive research and education partnership to accelerate joint discovery and the application of translational medical research.  The seed grant awards mark the first of many joint research collaborations. UVA’s Translational Health Research Institute of Virginia, which facilitates translational health research across UVA, and Inova’s Translational Medicine Institute, are helping support these research projects.

    This seed funding will help launch projects with broad impact, improving the health of people of all ages and states of health. The goal is to develop research data that can then be used to seek outside funding to continue the research and apply the learnings to improve patient outcomes. Research projects funded through the program include:

    • Learning how the gut microbiome – the bacteria that live inside us – may influence early childhood obesity.
    • Identifying and studying potential three-drug combinations to treat ovarian cancer.
    • Confirming a biomarker that may predict patients at high risk for heart disease.
    • Determining whether a mindfulness-based stress reduction program to prevent excess weight gain in obese pregnant women improves outcomes for mothers and babies.
    • Determining the impact of how babies are fed on their growth and the development of their gut microbiome.
    • Examining the gut microbiome of pediatric leukemia patients and how it may make them more susceptible to childhood obesity.
    • Seeking to identify gene variations that could identify patients at risk for heart failure.
    • Learning how dying cells and proteins may impact diseases that affect an individual’s metabolism.
    • Studying a new class of circular DNA – microDNA – along with microdeletions and how they manifest in men and women.

    “It’s exciting to see the first fruits of our partnership in the funding of exciting and promising translational medical research,” said Todd Stottlemyer, CEO, Inova Center for Personalized Health. “We have intentionally chosen projects that will benefit greatly from combining our individual knowledge and resources.”

    “We are excited to bring together researchers from UVA and Inova to work collaboratively on these projects that can help improve the lives of patients across Virginia and beyond,” said David S. Wilkes, MD, dean of the UVA School of Medicine.

    ####

    About Inova
    Inova is a global leader in personalized health, which leverages precision medicine together with more patient-centric services to predict, prevent and treat disease, enabling individuals to live longer, healthier lives. At Inova, we serve more than 2 million people each year from throughout the Washington, DC, metro area and beyond.

    We are shaping the future of health through our integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes.  Our commitment to health and wellness is further reflected in our sustainable practices. Inova is home to world-class researchers, expert medical specialists and renowned scientists, who are driving innovation to improve patient care, prevent disease and promote wellness. For more information, visit inova.org, or find Inova on FacebookTwitter and LinkedIn.

    About the University of Virginia

    The University of Virginia is distinctive among public institutions of higher education. Founded by Thomas Jefferson in 1819, the University continues in its mission to develop tomorrow’s leaders who are well prepared to help shape the future of the nation and the world. The University is highly selective, accepting only the best students and those who show the exceptional promise Jefferson envisioned.

    The University of Virginia is made up of eleven schools in Charlottesville plus the College at Wise in Southwest Virginia.

    For 2017, the University was ranked the No. 2 best public university by U.S. News and World Report. In the 18 years since U.S. News began ranking public universities as a separate category, UVA has ranked in the top three and continues to rank in the Top 30 among the best of all national universities, public and private.

cville store